QuidelOrtho
QDEL
#4767
Rank
โ‚น169.41 B
Marketcap
โ‚น2,494
Share price
-0.22%
Change (1 day)
-21.68%
Change (1 year)
Quidel is an American manufacturer of diagnostics testings that can be used to diagnose infectious diseases as well as cardiovascular and metabolic diseases.

QuidelOrtho (QDEL) - Total liabilities

Total liabilities on the balance sheet as of September 2025 : โ‚น326.88 Billion

According to QuidelOrtho's latest financial reports the company's total liabilities are โ‚น326.88 Billion. A companyโ€™s total liabilities is the sum of all current and non-current debts and obligations.

QuidelOrtho - Total liabilities on balance sheet (from 2001 to 2025)

Total liabilities by year

Year Total liabilities Change
2024-12-31โ‚น295.02 B-0.37%
2023-12-31โ‚น296.13 B-8.74%
2022-12-31โ‚น324.47 B770.15%
2021-12-31โ‚น37.29 B-5.31%
2020-12-31โ‚น39.37 B57.31%
2019-12-31โ‚น25.03 B-5.98%
2018-12-31โ‚น26.62 B-41.11%
2017-12-31โ‚น45.21 B254.64%
2016-12-31โ‚น12.74 B2.14%
2015-12-31โ‚น12.48 B-2.69%
2014-12-31โ‚น12.82 B335.24%
2013-12-31โ‚น2.94 B27.2%
2012-12-31โ‚น2.31 B-53.16%
2011-12-31โ‚น4.94 B8.15%
2010-12-31โ‚น4.57 B147.08%
2009-12-31โ‚น1.85 B63.38%
2008-12-31โ‚น1.13 B10.46%
2007-12-31โ‚น1.02 B-2.58%
2006-12-31โ‚น1.05 B-12.06%
2005-12-31โ‚น1.19 B22.83%
2004-12-31โ‚น0.97 B-22.07%
2003-12-31โ‚น1.25 B31.47%
2002-12-31โ‚น0.95 B-10.32%
2001-12-31โ‚น1.06 B

Total liabilities for similar companies or competitors

Company Total liabilities differencediff. Country
Meridian Bioscience
VIVO
โ‚น8.53 B-97.39%๐Ÿ‡บ๐Ÿ‡ธ USA
Becton Dickinson
BDX
โ‚น2.643 T 708.78%๐Ÿ‡บ๐Ÿ‡ธ USA
Thermo Fisher Scientific
TMO
โ‚น4.659 T 1,325.40%๐Ÿ‡บ๐Ÿ‡ธ USA
OraSure Technologies
OSUR
โ‚น5.49 B-98.32%๐Ÿ‡บ๐Ÿ‡ธ USA
Danaher
DHR
โ‚น2.588 T 691.96%๐Ÿ‡บ๐Ÿ‡ธ USA
PerkinElmer
PKI
โ‚น593.31 B 81.50%๐Ÿ‡บ๐Ÿ‡ธ USA